Description
This newsletter makes the case for routine dual kidney assessment—estimated glomerular filtration rate (eGFR) plus urine albumin‑to‑creatinine ratio (UACR)—as a standard practice to detect CKM early and trigger organ‑protective treatment. It explains why UACR complements eGFR by identifying early glomerular injury often missed by creatinine alone, summarises therapeutic implications (RAS inhibitors and SGLT2 inhibitors first‑line; add nonsteroidal MRAs or GLP‑1 therapy if albuminuria persists), and offers a practical systems-level recommendation: embed automatic UACR orders with diabetic and hypertensive creatinine panels to close the CKD detection gap and enable timely intervention.